Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Robert Iannone

Evp, Global Head Of R&D & Cmo at Jazz Pharmaceuticals plc (JAZZ)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $20.4M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 31SEC JAZZJazz Pharmaceuticals plc Sell Plan 18,187124,420 held (−13%) $247.86 $4.5M -11.9%
Aug 31SEC JAZZJazz Pharmaceuticals plc Sell Plan 11,423112,997 held (−9%) $248.67 $2.8M -12.2%
Aug 31SEC JAZZJazz Pharmaceuticals plc Sell Plan 18,11394,884 held (−16%) $250.02 $4.5M -12.6%
Aug 31SEC JAZZJazz Pharmaceuticals plc Sell Plan 19,63975,245 held (−21%) $250.60 $4.9M -12.8%
Aug 31SEC JAZZJazz Pharmaceuticals plc Sell Plan 9,25965,986 held (−12%) $251.95 $2.3M -13.3%
Aug 31SEC JAZZJazz Pharmaceuticals plc Sell Plan 30065,686 held (−0%) $252.76 $76K -13.6%
Nov 19SEC JAZZJazz Pharmaceuticals plc Sell Plan 7,15972,628 held (−9%) $168.26 $1.2M +29.8%
  • Sell

    Evp, Global Head Of R&D & Cmo Robert Iannone sold $4.5M of JAZZ at $247.86 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Global Head Of R&D & Cmo Robert Iannone sold $2.8M of JAZZ at $248.67 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Global Head Of R&D & Cmo Robert Iannone sold $4.5M of JAZZ at $250.02 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Global Head Of R&D & Cmo Robert Iannone sold $4.9M of JAZZ at $250.60 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Global Head Of R&D & Cmo Robert Iannone sold $2.3M of JAZZ at $251.95 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Global Head Of R&D & Cmo Robert Iannone sold $76K of JAZZ at $252.76 — pre-scheduled 10b5-1 plan sale.